Spruce Bio jumps after breakthrough therapy status for enzyme replacement therapy
Source: SeekingAlpha
2025-10-06 15:23:17 ET
More on Spruce Biosciences
- Seeking Alpha’s Quant Rating on Spruce Biosciences
- Historical earnings data for Spruce Biosciences
- Financial information for Spruce Biosciences
Read the full article on Seeking Alpha
For further details see:
Spruce Bio jumps after breakthrough therapy status for enzyme replacement therapy
Spruce Biosciences Inc.
NASDAQ: SPRB
SPRB Trading
4.51% G/L:
$66.4172 Last:
20,977 Volume:
$62.48 Open:
SPRB Latest News
March 09, 2026 07:05:00 am
Spruce Biosciences Reports Full Year 2025 Financial Results and Provides Corporate Updates
SPRB Stock Data
$90,018,117
658,278
2.53%
34
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
